PD-L1 Expression Guidance on Sintilimab Versus Pembrolizumab with or Without Platinum-Doublet Chemotherapy in Untreated Patients with Advanced Non-Small Cell Lung Cancer (CTONG1901): A Phase 2, Randomized, Controlled Trial.
SCIENCE BULLETIN（2024）
关键词
PD-1 inhibitor,Non-small cell lung cancer,Pembrolizumab,Sintilimab,PD-L1 expression
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要